StonvexLoading…
StonvexStonvexStonvexCore line items from SRTA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-03 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $68.12M | $67.38M | $197.14M | $130.35M | $125.11M |
Operating Income | Not available | $-2.97M | $-22.35M | $-15.95M | $-12.54M |
Net Income | Not available | $2.15M | $41.35M | $50.18M | $-7.24M |
EPS (Diluted) | $0.01 | $0.03 | $0.50 | $0.62 | $-0.09 |
Total Assets | Not available | $327.62M | $325.47M | $335.08M | $257.92M |
Total Liabilities | Not available | $41.89M | $46.40M | $52.08M | $34.82M |
Cash & Equivalents | Not available | $58.72M | $30.97M | $22.75M | $58.75M |
Free Cash Flow OCF − CapEx | Not available | $-1.29M | $-58.51M | $-48.35M | $-8.23M |
Shares Outstanding | Not available | 90.17M | 82.09M | 81.22M | 80.60M |